Does following CONSORT make a trial high quality?

No. CONSORT ensures a trial is reported completely and transparently. A trial can be fully CONSORT-compliant in its reporting and still be judged at high risk of bias; reporting completeness and methodological quality are separate things.

What is the CONSORT flow diagram for?

It tracks participants from enrolment through randomisation, follow-up, and analysis, making losses, exclusions, and the analysed population visible so readers can see whether attrition might threaten the trial's conclusions.

CONSORT Statement and RCT Reporting

The CONSORT (Consolidated Standards of Reporting Trials) Statement is a reporting guideline that specifies the minimum information a published randomised controlled trial should contain. Built around a checklist and a participant flow diagram, it aims to ensure that trials are described transparently enough for readers to judge their validity and for the results to be used reliably.

Definition

CONSORT is an evidence-based, expert-consensus reporting guideline consisting of a checklist of essential items and a flow diagram that authors use to describe how a parallel-group randomised trial was designed, conducted, analysed, and interpreted.

Scope

This topic covers what CONSORT is, the structure of its checklist and flow diagram, what it does and does not assess, and how it supports the critical appraisal of randomised trials. CONSORT governs reporting, not the conduct of a trial; this entry treats it as a transparency standard and not as clinical guidance.

Core questions

What minimum information should a randomised trial report include?
How do the CONSORT checklist and flow diagram support transparent reporting?
What is the difference between reporting completeness (CONSORT) and risk of bias (appraisal tools)?
How does CONSORT relate to trial registration and to extensions for other trial designs?

Key concepts

Reporting checklist
Participant flow diagram
Allocation concealment and blinding (as reported items)
Intention-to-treat reporting
Pre-specified versus reported outcomes
Reporting completeness versus internal validity

Mechanisms

CONSORT works by enumerating, item by item, the methodological and analytical details a trial report must disclose — from how the randomisation sequence was generated and concealed, through blinding and the handling of the participant flow, to the pre-specified primary outcome and the analysis population (Schulz 2010). The accompanying Explanation and Elaboration document gives the rationale and empirical basis for each item and model text (Moher 2010). The flow diagram tracks participants from enrolment through allocation, follow-up, and analysis, making attrition and exclusions visible. By standardising disclosure, CONSORT gives an appraiser the raw material needed to judge bias; tools such as RoB 2 then use that disclosed information to reach a risk-of-bias judgement (Sterne 2019), illustrating the complementary relationship between reporting standards and appraisal instruments.

Clinical relevance

CONSORT underpins the readability and appraisability of the randomised trials that inform clinical practice and guidelines. It describes how trial evidence should be reported so it can be evaluated; it characterises the quality of evidence reporting and is not a source of diagnostic or treatment recommendations for individual patients.

Evidence & guidelines

CONSORT is endorsed by many leading journals and is coordinated through the EQUATOR Network alongside other reporting guidelines. The current version is the CONSORT 2010 Statement and its Explanation and Elaboration (Schulz 2010; Moher 2010), which superseded the 2001 revision (Moher 2001); numerous extensions adapt the core checklist to specific designs and interventions. Adherence to CONSORT documents transparency of reporting and is distinct from a study's risk of bias, which is judged with appraisal tools such as RoB 2 (Sterne 2019).

History

CONSORT emerged in the mid-1990s from converging efforts to standardise trial reporting after evidence that incomplete reporting obscured trial quality. A revised statement appeared in 2001 (Moher 2001), and the current CONSORT 2010 Statement with its detailed Explanation and Elaboration followed (Schulz 2010; Moher 2010). It became a template for the wider movement of reporting guidelines now coordinated by the EQUATOR Network, and its design influenced later instruments for other study types.

Debates

Does CONSORT measure trial quality?: CONSORT assesses completeness of reporting, not how well a trial was conducted; using checklist adherence as a quality or validity score conflates transparency with internal validity, a distinction the guideline's authors emphasise.

Key figures

Douglas Altman
David Moher
Kenneth Schulz

Seminal works

schulz-2010-consort
moher-2010-consort-ee
moher-2001-consort

Frequently asked questions

Does following CONSORT make a trial high quality?: No. CONSORT ensures a trial is reported completely and transparently. A trial can be fully CONSORT-compliant in its reporting and still be judged at high risk of bias; reporting completeness and methodological quality are separate things.
What is the CONSORT flow diagram for?: It tracks participants from enrolment through randomisation, follow-up, and analysis, making losses, exclusions, and the analysed population visible so readers can see whether attrition might threaten the trial's conclusions.